Opexa therapeutics corporate presentation october 2014
What To Look For In Peregrine Pharmaceuticals Q2 Earnings
1 Endocrinologic and Metabolic Drugs Advisory Committee Meeting January 15, 2003 Sponsor Presentation Aldurazyme ® (laronidase)
C1 Esterase Inhibitor (Human) (Cinryze™) Lev Pharmaceuticals, Inc.
CTD Module 1
1 ENTEREG ® (Alvimopan) Part 1: Efficacy and General Safety Evaluation Clinical Evaluation of NDA 21-775 ENTEREG ® (Alvimopan) Part 1: Efficacy and General.
